Table 4.
Telepsychiatrists' Medication Adjustments for Participants Who Have Not Attained the “Treat to Target” Goal of 50% Reduction in ADHD Symptoms
| Percentage of subjects without 50% improvement based on CATTS Rating Scale who received a medication change | |||||
|---|---|---|---|---|---|
| ADHD subtype | Session 2* % (n) | Session 3* % (n) | Session 4* % (n) | Session 5 % (n) | Session 6 % (n) |
| ADHD alone (n=17) | 68.8 (11) | 23.1 (3) | 28.6 (2) | 33.3 (3) | 10.0 (1) |
| ADHD+1 comorbidity (n=48) | 64.4 (29) | 58.3 (21) | 43.3 (13) | 26.9 (7) | 12.5 (3) |
| ADHD+2 comorbidities (n=34) | 90.6 (29) | 70.8 (17) | 60.0 (12) | 66.7 (16) | 14.3 (3) |
| All subgroups (n=99) | 74.2 (69) | 56.2 (41) | 47.4 (27) | 44.1 (26) | 12.7 (7) |
*
p<0.05 for comparison among the three groups at each session.
CATTS, Children's Attention-Deficit Hyperactivity Disorder Telemental Health Treatment Study; ADHD, attention-deficit/hyperactivity disorder; ADHD+1, ADHD with a comorbid oppositional defiant disorder behavior or anxiety disorder symptoms; ADHD+2, ADHD with two comorbidities; i.e., oppositional defiant disorder behaviors and anxiety disorder symptoms.